Experimental peptide treatment could triple survival rates in severe blood loss cases

Researchers at the Hebrew University of Jerusalem and the IDF Medical Corps have discovered a promising new therapeutic approach to treating hemorrhagic shock, a life-threatening condition caused by severe blood loss that remains the leading cause of preventable death in trauma cases globally.

unhinged black guy calls for race war and open violence against white people #shorts
- Decoding the Enigma of the Snowball Earth - Arya Chandran
- The Advancement of Wi-Fi: How Wi-Fi 7 is Shaping the Future - Michael A. Medeiros
- The best Apple deals you can get right now: Save on iPads, AirPods, MacBooks and more - Valentina Palladino,Amy Skorheim,Jeff Dunn
- Run Games surprise-launches Football Heroes League - Rachel Kaser
- Trump: Iran Must Dismantle Its Nuclear Program, 'Nothing Less'
- How To Make Money On eBay Without Selling Anything? - Aamir Zahoor

This Company Is Killing Apple!
- Stellar Performance by Reform UK in Local Elections Confirms Nigel Farage as a Very Strong Contender for the Role of Next British Prime Minister - Diana Zapata
- Autism rate rises slightly; RFK Jr. claims he’ll “have answers by September” - Beth Mole
- 63,000 Pounds of Oats Recalled Over Safety Concerns, FDA Warns - Jenna Anderson
- EXCLUSIVE| Bold and Beautiful: Maia Hazel Talks Overcoming Barriers, Activism, and Pushing Boundaries in Entertainment - Aayush Sharma
- Microsoft Triumphs in OpenAI Turbulence: A New Era for AI Leadership - Sean George
- National Best Friends Day 2024: Significance and How to Celebrate - Bertha Stephens